09:42 AM EST - Medicenna Therapeutics Corp. : Announced the appointment of Humphrey Gardner, M.D., as Chief Medical Officer (CMO) to lead the development strategy and execution of Medicenna’s clinical programs. Medicenna Therapeutics Corp.
shares T.MDNA are trading unchanged at $0.39.
